Beyond Air (XAIR) Total Debt Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | 150.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150.56% |
| Sep 30, 2025 | -9.94% |
| Jun 30, 2025 | -36.35% |
| Mar 31, 2025 | -36.82% |
| Dec 31, 2024 | -39.56% |
| Sep 30, 2024 | -21.80% |
| Jun 30, 2024 | 8.69% |
| Mar 31, 2024 | 955.85% |
| Dec 31, 2023 | 218.20% |
| Sep 30, 2023 | 197.69% |
| Jun 30, 2023 | 65.26% |
| Mar 31, 2023 | -20.71% |
| Dec 31, 2022 | 41.61% |
| Sep 30, 2022 | 1,617.86% |
| Jun 30, 2022 | 77.54% |
| Mar 31, 2022 | 66.43% |
| Dec 31, 2021 | -41.38% |
| Sep 30, 2021 | -93.76% |
| Jun 30, 2021 | 5.95% |
| Mar 31, 2021 | -76.17% |
| Dec 31, 2020 | 3,401.19% |
| Sep 30, 2020 | 1,881.66% |
| Jun 30, 2020 | 1,455.93% |
| Mar 31, 2020 | 740.57% |
| Dec 31, 2017 | -66.67% |
| Dec 31, 2016 | 290.00% |